Trial Profile

ONO-4059 phase II study: Multicenter, open-label, uncontrolled, single-arm study in patients with refractory pemphigus

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 05 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tirabrutinib (Primary)
Indications Pemphigus
Focus Therapeutic Use
Sponsors Ono Pharmaceutical

Most Recent Events

02 Sep 2022 Planned End Date changed from 1 Jan 2023 to 31 Dec 2026.
01 Sep 2021 Status changed to completed, as per results published in the Journal of Dermatological Science
17 Dec 2018 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com